Bolt Biotherapeutics, Inc. Common Stock (BOLT) Stock Price

BOLTStock

$3.85−27.38%52W

Market Cap$7.42M

P/E—

PEG Ratio—

Div yield—

Beta1.01

BOLT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-31.16%

Price vs S&P 500 (4W)-10.02%

VGM Score50.65

Book Value / Share (Quarterly)$10.32

P/TBV (Annual)0.20x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)10.33%

Cash Flow / Share (Quarterly)$-18.00

Price vs S&P 500 (YTD)-43.56%

Net Profit Margin (TTM)-455.15%

EPS (TTM)$-16.34

10-Day Avg Trading Volume0.04M

EPS Excl Extra (TTM)$-16.34

Revenue Growth (5Y)101.79%

EPS (Annual)$-17.85

ROI (Annual)-125.92%

Net Profit Margin (5Y Avg)-2299.04%

Cash / Share (Quarterly)$11.91

Revenue Growth QoQ (YoY)-97.87%

ROA (Last FY)-58.81%

Revenue Growth TTM (YoY)78.64%

EBITD / Share (TTM)$-16.85

ROE (5Y Avg)-77.69%

Operating Margin (TTM)-486.21%

Cash Flow / Share (Annual)$-20.79

P/B Ratio0.31x

P/B Ratio (Quarterly)0.39x

Net Income / Employee (Annual)$-1,451,100

EV / Revenue (TTM)-0.83x

ROA (TTM)-48.23%

EPS Incl Extra (Annual)$-17.85

Current Ratio (Annual)3.59x

Quick Ratio (Quarterly)3.14x

3-Month Avg Trading Volume0.03M

52-Week Price Return-27.38%

Revenue / Employee (TTM)$282,600

Tangible BV / Share (Quarterly)$3.38

P/S Ratio (Annual)0.80x

Asset Turnover (Annual)0.14x

52-Week High$7.20

Operating Margin (5Y Avg)-2253.29%

EPS Excl Extra (Annual)$-17.85

CapEx CAGR (5Y)-53.35%

26-Week Price Return-19.91%

Quick Ratio (Annual)3.40x

13-Week Price Return-18.52%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)3.51x

Enterprise Value$-5.43M

Revenue / Share Growth (5Y)265.60%

Asset Turnover (TTM)0.11x

Revenue / Employee (Annual)$334,600

Pretax Margin (Annual)-433.74%

Cash / Share (Annual)$14.32

3-Month Return Std Dev73.54%

Net Income / Employee (TTM)$-1,286,100

ROE (Last FY)-125.92%

EPS Basic Excl Extra (Annual)$-17.85

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-16.34

ROI (TTM)-100.90%

P/S Ratio (TTM)0.95x

Pretax Margin (5Y Avg)-2299.04%

Revenue / Share (Annual)$4.12

Tangible BV / Share (Annual)$4.54

Price vs S&P 500 (52W)-45.69%

Year-to-Date Return-31.60%

5-Day Price Return17.71%

EPS Normalized (Annual)$-17.85

ROA (5Y Avg)-47.24%

Net Profit Margin (Annual)-433.74%

Month-to-Date Return-6.27%

Cash Flow / Share (TTM)$-1.84

EBITD / Share (Annual)$-18.62

Operating Margin (Annual)-469.30%

ROI (5Y Avg)-77.69%

EPS Basic Excl Extra (TTM)$-16.34

P/TBV (Quarterly)0.27x

P/B Ratio (Annual)0.40x

Pretax Margin (TTM)-455.15%

Book Value / Share (Annual)$13.80

Price vs S&P 500 (13W)-21.31%

Beta1.01x

Revenue / Share (TTM)$3.87

ROE (TTM)-100.90%

52-Week Low$3.13

gGradeC

mGradeC

vgmGradeC

BOLT Earnings Surprise History

Q2 25-4.46est. -6.27

Q3 25-3.72est. -5.43

Q4 25-2.98est. -5.52

Q2 26-4.57est. -21.06

BOLT Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.90

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
BOLTBolt Biotherapeutics, Inc. Common Stock	—	C	C	$3.85
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Bolt Biotherapeutics, Inc. Common Stock

Bolt Biotherapeutics is a clinical-stage immuno-oncology company developing tumor-targeted therapies that activate both innate and adaptive immune responses. The company's proprietary Boltbody ISAC platform combines tumor-targeting antibodies with immune-stimulating payloads, leveraging deep expertise in myeloid biology. Its pipeline includes three candidates: BDC-1001, BDC-3042, and a next-generation ISAC therapeutic.